Advancing TMS since 1992

EUR

DE

US

BR

EUR

DE

US

BR

Butterfly (figure 8), Static cooling

MCF-P-B70

A butterfly shaped placebo coil with static cooling. The MCF-P-B70 coil has a mechanical outline, sound level, and available stimuli identical to MCF-B70. Butterfly-shaped, with static cooling. The coil’s magnetic shield reduces the magnetic field by approximately 80%. Equipped with a trigger button on the handle for ease of operation. Note: This is a placebo coil with no active magnetic stimulation.

MagPro R20
MagPro R20+
MagPro R20+ with Express Solution
MagPro R30
MagPro R30 inclusive MagOption
MagPro X100
MagPro X100 inclusive MagOption

Static cooling

Placebo

Compatible with Neuro Navigation

Product details

Stay updated

Explore our instagram

Visit our instagram

Join us on Wednesday, April 30th for an exclusive

Join us on Wednesday, April 30th for an exclusive webinar featuring John Rothwell, Professor Emeritus of Human Neurophysiology, UCL Queen Square Institute of Neurology in London. ⁠
⁠
Prof. Rothwell will guide us through a TMS journey, sharing insight into his pioneering work on Theta Burst Stimulation (TBS) of the Human Motor Cortex. ⁠
⁠
During the session Prof. Rothwell will talk about the steps which led him and coworker Ying-Zu Huang to develop a novel method of delivering rTMS based on patterns of TBS, while providing a background on how TBS interacts and influences cortical excitability.⁠
⁠
Overview ⁠
• The Development of Theta Burst TMS⁠
• How does Theta Burst TMS achieve the same effects as regular rTMS in a much shorter time⁠
• Are there any disadvantages of Theta Burst TMS?⁠
• The future of Theta Burst TMS⁠
⁠
📅 Date: April 30th⁠
🕛 Time: 1:00 - 2:00 PM (CET Time) / 7:00-8:00 AM (EST Time)⁠
⁠
Register now to secure your spot! Link in the bio.⁠
Can't join us live? Sign up to receive the recording.⁠
⁠
⁠
The views and opinions expressed in this webinar do not necessarily reflect the official policy or position of MagVenture or any of its affiliates. MagVenture devices are only for sale by or on the order of a physician.⁠
MagVenture TMS Therapy with TBS is FDA-cleared for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode (k173620)⁠
MagVenture TMS Therapy with TBS is CE marked for treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from two prior antidepressant medications, at or above the minimal effective dose and duration in the current episode.

TMS (Transcranial Magnetic Stimulation) is a non-p

TMS (Transcranial Magnetic Stimulation) is a non-pharmacological therapy recommended by the American Psychiatric Association since 2010 for treating Major Depressive Disorder.⁠
⁠
During treatment, magnetic pulses are delivered through a coil to stimulate nerve cells in the brain areas that regulate mood. Repeated stimulation of these regions can have an antidepressant effect on those with Major Depressive Disorder.⁠
⁠
Each session lasts about 20-30 minutes on average. Since TMS is non-invasive, it doesn't require anesthesia, doesn't affect cognitive function, and has no systemic side effects. The most common side effects of TMS are headache and discomfort at the stimulation site. In rare cases seizures may occur, but the risk is very low (<0.1% per patient) when treatment is performed according to the safety recommendations for TMS therapy.⁠
⁠
Learn more about MagVenture on our website. Link in the BIO👆⁠
⁠
#InnovativeTherapy #AccessToCare #MagVentureCares #MagVenture #Neuromodulation #MentalHealth #MentalHealthMatters #HealthcareInnovation #rTMS #Neuroscience #TMSResearch #TMS⁠ #MagneticStimulation

Today, on World Bipolar Day, we join the global ef

Today, on World Bipolar Day, we join the global effort to raise awareness, reduce stigma, and promote understanding of bipolar disorder. 🌍💙⁠
⁠
Celebrated every March 30th— the birthday of Vincent Van Gogh, who was posthumously diagnosed as probably having a bipolar condition —this day is a reminder that education, compassion, and access to care can make a difference.⁠
⁠
Let’s work together to build a more informed and compassionate world. You are not alone. 💙⁠
⁠
Learn more about MagVenture on our website. Link in the BIO👆⁠
⁠
#BrainStimulation #InnovativeTherapy #AccessToCare #MagVentureCares #MagVenture #Neuromodulation #MentalHealth #MentalHealthMatters #HealthcareInnovation #rTMS #Neuroscience #TMSResearch #TMS⁠ #Magneticstimulation #MagVentureTherapy

According to the World Health Organization (WHO),

According to the World Health Organization (WHO), depression arises from a complex interplay of chemical imbalances within the brain. Key players in this intricate network are the neurotransmitters serotonin and norepinephrine. When the levels of these chemicals become imbalanced, depression can take hold.⁠
⁠
Pinpointing the exact triggers of these imbalances remains a challenge. While the causes of depression are not fully understood, they can stem from a combination of biological factors and environmental influences, such as significant stress. Identifying the underlying factors contributing to depressive episodes is crucial for effective treatment.⁠
⁠
We recognize the importance of this research and the tireless work of the people behind it.⁠
⁠
#BrainStimulation #InnovativeTherapy #AccessToCare #MagVentureCares #MagVenture #Neuromodulation #MentalHealth #MentalHealthMatters #HealthcareInnovation #rTMS #Neuroscience #TMSResearch #TMS⁠ #MagneticStimulation #MagVentureTherapy #Diagnostic #Research

Join us for an exclusive MagVenture Workshop on Fr

Join us for an exclusive MagVenture Workshop on Friday, April 4, just before the EPA Conference in Madrid!⁠
⁠
Designed for clinicians looking to start or expand their TMS practice, these workshops offer expert insights, hands-on experience, and networking opportunities.⁠
⁠
What to expect? ⁠
• Special guest speaker Dr. Álvaro Moleón, leading psychiatrist in TMS clinic ⁠
◦ Workshop 1: Starting a TMS clinic – challenges, lessons & solutions ⁠
◦ Workshop 2: Challenging patient groups in TMS – identification & treatment ⁠
• Insights into new research & emerging treatments with Claus Mathiesen ⁠
• Hands-on TMS session ⁠
• Q&A with leading TMS professionals ⁠
⁠
⁠
👉 Register now! Places are limited. Link in Bio

Join us at the EPA 2025, Booth Number 13 in Madrid

Join us at the EPA 2025, Booth Number 13 in Madrid, Spain.⁠
⁠
Don’t miss this opportunity to learn, network, and advance your expertise. Click on the events section on our website for more information. Link in BIO. 👆⁠
⁠
#BrainStimulation #InnovativeTherapy #AccessToCare #MagVentureCares #MagVenture #Neuromodulation #MentalHealth #MentalHealthMatters #HealthcareInnovation #rTMS #Neuroscience #TMSResearch #TMS⁠ #Magneticstimulation #MagVentureTherapy